bcv
Brincidofovir treatment efficacy in two well characterized orthopoxvirus infection models of smallpox
ASM Biothreats 2020
BCV Publications
bcv
Efficacy of delayed brincidofovir treatment against a lethal rabbitpox virus challenge in New Zealand White rabbits
Antiviral Res 2017
bcv
Brincidofovir Is Not a Substrate for the Human Organic Anion Transporter 1: A Mechanistic Explanation for the Lack of Nephrotoxicity Observed in Clinical Studies
Ther Drug Monit. 2016
bcv
The efficacy and pharmacokinetics of brincidofovir for the treatment of lethal rabbitpox virus infection: A model of smallpox disease.
Antiviral Res 2015
bcv
Co-administration of the broad-spectrum antiviral, brincidofovir (CMX001), with smallpox vaccine does not compromise vaccine protection in mice challenged with ectromelia virus
Antiviral Res. 2014
bcv
In vitro efficacy of brincidofovir against variola virus
Antimicrob Agents Chemother 2014
bcv
Development of CMX001 for the treatment of poxvirus infections
Viruses 2010
bcv
Alkoxyalkyl prodrugs of acyclic nucleoside phosphonates enhance oral antiviral activity and reduce toxicity
Antiviral Res. 2009
bcv
Synergistic efficacy of the combination of ST-246 with CMX001 against orthopoxviruses
Antimicrob.Agents Chemother. 2007
bcv
Rabbitpox virus and vaccinia virus infection of rabbits as a model for human smallpox
Journal of Virology 2007